PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers
- Jacob Atsmon
- , Irina Cherniakov
- , Dvora Izgelov
- , Amnon Hoffman
- , Abraham J. Domb
- , Lisa Deutsch
- , Frederic Deutsch
- , Daphna Heffetz
- , Hagit Sacks
- Tel Aviv Sourasky Medical Center
- Hebrew University of Jerusalem
- BioStats Statistical Consulting Ltd
- PhytoTech Therapeutics
Research output: Contribution to journal › Article › peer-review
88
Scopus
citations